跳转至内容
Merck
  • 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.

2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.

Cancer research (2004-12-18)
Kasem Nithipatikom, Michael P Endsley, Marilyn A Isbell, John R Falck, Yoshiki Iwamoto, Cecilia J Hillard, William B Campbell
摘要

Endocannabinoids have been implicated in cancer. Increasing endogenous 2-arachidonoylglycerol (2-AG) by blocking its metabolism inhibits invasion of androgen-independent prostate cancer (PC-3 and DU-145) cells. Noladin ether (a stable 2-AG analog) and exogenous CB1 receptor agonists possess similar effects. Conversely, reducing endogenous 2-AG by inhibiting its synthesis or blocking its binding to CB1 receptors with antagonists increases the cell invasion. 2-AG and noladin ether decrease protein kinase A activity in these cells, indicating coupling of the CB1 receptor to downstream effectors. The results suggest that cellular 2-AG, acting through the CB1 receptor, is an endogenous inhibitor of invasive prostate cancer cells.

材料
货号
品牌
产品描述

Sigma-Aldrich
RHC 80267, ≥98% (HPLC), solid